Quality of Life and Satisfaction With Outcome Among Prostate Cancer Survivors

2021 ◽  
pp. 55-60
Author(s):  
Niranjan Sathianathen ◽  
Philipp Dahm
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
External Beam Radiotherapy ◽  
Primary Treatment ◽  
External Beam ◽  
Prostate Cancer Survivors ◽  
Hormonal Function ◽  
Partner Satisfaction ◽  
The Impact

This chapter summarizes the design, findings, and implications of an observational study of men with prostate cancer who chose prostatectomy, brachytherapy, or external-beam radiotherapy as primary treatment. The chapter provides detailed information on the unique impact of prostatectomy, external-beam radiotherapy, and brachytherapy on quality-of-life domains related to urinary, sexual, bowel, and hormonal function. It also describes the impact of patient quality of life on partner satisfaction.

Prospective Study Analyzing Quality of Life and Toxicities in Prostate Cancer Patients Treated with Combined External Beam Radiotherapy and Brachytherapy

Brachytherapy ◽  
2016 ◽  
Vol 15 ◽  
pp. S198-S199
Author(s):  
Elisabeth Arrojo ◽  
Esther Garcia Diaz ◽  
Pedro J. Prada Gomez ◽  
Beatriz Suarez Baena ◽  
Michael Ghilezan ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
Prospective Study ◽  
Cancer Patients ◽  
External Beam Radiotherapy ◽  
External Beam

Quality of life in intermediate or high risk prostate cancer patients treated by 3-D external beam radiotherapy and brachytherapy with or without androgen deprivation

2006 ◽  
Vol 24 (18_suppl) ◽  
pp. 14587-14587
Author(s):  
B. Guix ◽  
T. M. Lacorte ◽  
F. Guedea
Keyword(s):  
Quality Of Life ◽  
Prostate Cancer ◽  
High Risk ◽  
Sexual Function ◽  
External Beam Radiotherapy ◽  
External Beam ◽  
High Risk Prostate Cancer ◽  
Risk Prostate Cancer

14587 Background: To elucidate long-term changes in health-related quality-of-life (HRQOL) outcomes by prospectively re-evaluating a cohort of intermediate- or high-risk prostate cancer patients treated by a combination of 3-D External Beam Radiotherapy (EBRT) and Brachytherapy (BT) with or without androgen deprivation (AD). Methods: A cross-sectional survey was administered to 200 consecutive patients with intermediate (Gleason 7 or PSA 10–20 or T2A-B) or high (Gleason >7 and/or PSA >20 and/or >T2B) - Risk Prostate cancer who were treated by EBRT to the prostate followed by BT to the prostate given either by permanent 125-I seeds (LDR) or high dose rate (HDR) implants before treatment and at 6 months interval during 4 years follow-up. The EORTC CLQ-C30 with the PR-25 module was employed. HRQOL was compared among therapy groups. Comparisons between therapy groups was performed using regression models to control covariates. HRQOL of treatment parameters were evaluated. Distribution of responses for bowel-, urinary- and sexual-related functions were analyzed. Results: 200 patients completed the questionnaires. Significant changes in HRQOL were found depending of the time after treatment. After a temporal decline in HRQOL, an improvement owas found during the first 18 months after end of treatment. Significant improvement in the urinary irritative-obstructive performance (p < 0.006) was found after 6 months post-treatment. Bowel domains worsened after therapies (p < 0,05) but improved after 18 months follow-up (p < 0.02). Overall sexual HRQOL deteriorated depending greatly on treatment (p < 0.008). Patients who were given AD presented a significant lower Sexual Function values, that were difficult to recover after AD cessation (p < 0.007). No differences in HRQOL were found between LDR or HDR BT implants. Satisfaction with either treatment was high. Conclusions: After a decline in HRQOL after treatment, it recovered fully during follow-up. In patients treated by AD, sexual function was the most adversely affected quality-of-life domain. Sexual impairment induced by AD was difficult to recover. These results may be of assistance to men and to clinicians when making treatment decisions, mainly relating AD. No significant financial relationships to disclose.

Sign in / Sign up

Export Citation Format

Share Document